LEP and familial pancreatic carcinoma: Leptin overexpression promotes human pancreatic cancer xenograft growth and lymph node metastasis in mice, inducing the progression throughout the cell cycle and the expression of pancreatic cancer stem cell (CSC) markers (CD24+, CD44+, ESA+, ALDH+) [66].